Artemisinin-polyvinylpyrrolidone composites prepared by evaporative precipitation of nanosuspension for dissolution enhancement

Journal of Biomaterials Science, Polymer Edition

Volumn 22, Issue 1-3, 2011, Pages 363-378

  Kakran, M ^a   Sahoo, N G ^a   Li, L ^a   Judeh, Z ^b   Panda, P ^b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b Nanyang Technological University   (Singapore)

Author keywords

Artemisinin; crystallinity; dissolution; nanoparticles; polyvinylpyrrolidone

Indexed keywords

COMPOSITE MATERIALS; CRYSTALLINITY; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG PRODUCTS; NANOPARTICLES; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; POLYMERS; PRECIPITATION (CHEMICAL); SOLUBILITY; SYNTHESIS (CHEMICAL);

ARTEMISININ; DISSOLUTION EFFICIENCIES; EVAPORATIVE PRECIPITATION OF NANOSUSPENSION; MORPHOLOGICAL PROPERTIES; NANO-FABRICATION METHODS; PHASE-SOLUBILITY STUDIES; POLY VINYL PYRROLIDONE; X-RAY DIFFRACTION STUDIES;

DRUG DELIVERY;

ARTEMISININ; NANOPARTICLE; POVIDONE; ANTIINFECTIVE AGENT; ARTEMISININ DERIVATIVE; DRUG CARRIER; SUSPENSION;

ARTICLE; COMPOSITE MATERIAL; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG RELEASE; DRUG SOLUBILITY; EVAPORATION; EVAPORATIVE PRECIPITATION OF NANOSUSPENSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MATHEMATICAL MODEL; NANOFABRICATION; PARTICLE SIZE; PHASE TRANSITION; PHYSICAL CHEMISTRY; PRECIPITATION; PRIORITY JOURNAL; SUSPENSION; X RAY DIFFRACTION; CHEMICAL MODEL; CHEMISTRY; DIFFUSION; KINETICS; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; SYNTHESIS; TEMPERATURE; ULTRASTRUCTURE;

ANTI-INFECTIVE AGENTS; ARTEMISININS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMICAL PRECIPITATION; DIFFUSION; DRUG CARRIERS; DRUG LIBERATION; KINETICS; MICROSCOPY, ELECTRON, SCANNING; MODELS, CHEMICAL; NANOPARTICLES; PHASE TRANSITION; POVIDONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SUSPENSIONS; TEMPERATURE; X-RAY DIFFRACTION;

EID: 78649944597     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1163/092050610X486964     Document Type: Article

References (33)

1. C. A. Lipinski, F. Lombardo, B. W. Dominy and P. J. Feeney, Adv. Drug Deliv. Rev. 46, 3 (2001).
2. S. H. Yalkowsky, Techniques of Solubilization of Drugs. Marcel Dekker, New York, NY (1981).
3. C. Lipinski, Am. Pharm. Rev. 5, 82 (2002).
4. E. Merisko-Liversidge, Nanocrystals: Resolving Pharmaceutical Formulation Issues Associated with Poorly Water-Soluble Compounds in Particles. Marcel Dekker, Orlando, FL (2002).
5. B. Subramaniam, R. A. Rajewski and K. Snavely, J. Pharm. Sci. 86, 885 (1997).
6. B. C. Hancock and G. Zografi, J. Pharm. Sci. 86, 1 (1997).
7. M. J. Grau, O. Kayser and R. H. Muller, Int. J. Pharm. 196, 155 (2000).
8. R. Patel and M. Patel, J. Dispers. Sci. Technol. 29, 193 (2008).
9. D. Q. M. Craig, Int. J. Pharm. 231, 131 (2002).
10. P. Augustijns, A. D'Hulst, J. Van Daele and R. Kinget, J. Pharm. Sci. 85, 577 (1996).
11. L. B. Barradell and A. Fitton, Drugs 50, 714 (1995).
12. M. Kakran, N. G. Sahoo, L. Li, Z. Judeh, K. Chong and L. Loh, Int. J. Pharm. 383, 285 (2010).
13. S. S. Zhao, Analyst 112, 661 (1987).
14. N. G. Sahoo, A. Abbas, Z. Judeh, C. M. Li and K. H. Yuen, J. Pharm. Sci. 98, 281 (2009).
15. T. Higuchi and K. A. Connors, Adv. Anal. Chem. Instr. 4, 117 (1965).
16. J. W. Wong and K. H. Yuen, Drug Dev. Ind. Pharm. 29, 1035 (2003).
17. A. Martin, Physical Pharmacy, Physical Chemical Principles in the Pharmaceutical Sciences, 4th edn. Lea and Febiger, Philadelphia, PA (1993).
18. N. Ahuja, O. P. Katare and B. Singh, Eur. J. Pharm. Biopharm. 65, 26 (2007).
19. K. A. Khan, J. Pharm. Pharmacol. 27, 48 (1975).
20. J. W. Moore and H. H. Flanner, Pharm. Technol. 20, 64 (1996).
21. M. Labastie, R. Nacco and J. Cumps, J. Pharm. Biomed. Anal. 10, 1105 (1992).
22. P. Costa and J. J. S. Lobo, Eur. J. Pharm. Sci. 13, 123 (2001).
23. F. O. Costa, J. J. S. Sousa, A. A. C. C. Pais and S. J. Formosinho, J. Control. Rel. 89, 199 (2003).
24. A. A. Noyes and W. R. Whitney, J. Am. Chem. Soc. 19, 930 (1897).
25. S. R. Vippagunta, K. A. Maul, S. Tallavajhala and D. J. W. Grant, Int. J. Pharm. 236, 111 (2002).
26. H. Valizadeh, A. Nokhodchi, N. Qarakhani, P. Zakeri-Milani, S. Azarmi, D. Hassanzadeh and R. Lobenberg, Drug Dev. Ind. Pharm. 30, 303 (2004).
27. X. X. Chen, T. J. Young, M. Sarkari, R. O. Williams and K. P. Johnston, Int. J. Pharm. 242, 3 (2002).
28. D. Douroumis and A. Fahr, Colloids Surf. B: Biointerfaces 59, 208 (2007).
29. H. Sekikawa, M. Nakano and T. Arita, Chem. Pharm. Bull. 26, 118 (1978).
30. M. Cirri, P. Mura, A. M. Rabasco, J. M. Gines, J. R. Moyano and M. L. Gonzalez-Rodriguez, Drug Dev. Ind. Pharm. 30, 65 (2004).
31. W. L. Chiou, J. Pharm. Sci. 66, 989 (1977).
32. C. J. Ashwinkumar and C. A. Moji, Int. J. Pharm. 212, 177 (2001).
33. R. W. Korsemeyer, R. Gurney, E. Doelker, P. Buri and P. A. Peppas, Int. J. Pharm. 15, 25 (1983).